A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

NCT00236015 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
880
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Cephalon